LOOK CLOSER at the complete picture with CGM Quick 3 Step Guide 1-2-3 to interpret iPro™2 Professional CGM Report India Medtronic Pvt. Ltd. 1241 Solitaire Corporate Park, Bldg. 12, 4th Floor, Andheri-Ghatkopar Link Road, Andheri (E), Mumbai 400 093 Tel: +91 22 3307 4700/01/02/03 | Fax: +91 22 3307 4704 | e-mail: [email protected]Simple 2 Start. Easy 2 Evaluate. Pump therapy is simple for you and your patients Your partner for diabetes care Indications for Insulin Pump Therapy Ü High insulin requirements Ü Fear of Hypoglycemia Ü Complications associated with diabetes Ü Missed injections Ü Desire for improved lifestyle / flexibility Ü Elevated A1C Ü Glycemic fluctuations Ü Dawn phenomenon Ü Insulin resistance or glucose toxicity Ü Weight concerns Ü Gestational or pregnancy with type 2
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Pump therapy is simple foryou and your patientsYour partner for diabetes care
Indications for Insulin Pump Therapy
Ü High insulin requirements
Ü Fear of Hypoglycemia
Ü Complications associated with diabetes
Ü Missed injections
Ü Desire for improved lifestyle / flexibility
Ü Elevated A1C
Ü Glycemic fluctuations
Ü Dawn phenomenon
Ü Insulin resistance or glucose toxicity
Ü Weight concerns
Ü Gestational or pregnancy with type 2
Evaluate Pre-Prandial – (before meals)
Evaluate Post-Prandial – (2 to 3 hours after meals)
Evaluate Overnight – (12 am to 6 am)
Close Examinationof 3 Critical Periods
Daily Overlay
Help IdentifyCause and Effect
Quick Review ofGlucose Excursionsor Trends
3 Simple Steps
Support ReportInterpretation withCritical Patient Information
3PO
ST-PRA
NDIAL
Hyp
erglycem
ia3
POST-PRA
NDIAL
Hyp
oglycemia
1OVE
RNIGHT
Hyp
erglycem
ia1
OVE
RNIGHT
Hyp
oglycemia
2PR
E-PR
ANDIAL
Hyp
oglycemia
2PR
E-PR
ANDIAL
Hyp
erglycem
ia
This Guide is intended to provide healthcare professionals a simple 3 Step Methodology to interpret iPro™2 professional continuous glucose monitoring (CGM) reports.
You may use the information in the report to adjust therapies and/or suggest lifestyle changes for your patients. It is recommended that you make only one or two adjustments for your patient at a time to better understand the effect of each change on his/her glucose control.Note: The graphs shown in this guide are recreated artwork to illustrate glucose patterns. They are not produced by the actual software.
Note:
Patient Log Sheet
Simple 2 Start.Easy 2 Evaluate. 3 Simple Reports
Supported by Patient Log Sheet
Daily Summary
Overlay by Meal
Time BG Meal (food/drink) Medication Dosage Activity Duration
Dat
e:
Time BG Meal (food/drink) Medication Dosage Activity Duration
Dat
e:
Time BG Meal (food/drink) Medication Dosage Activity Duration
Dat
e:
Overnight Period - Hypoglycemia (12 am – 6 am)
Simple 2 Start.Easy 2 Evaluate.
3PO
ST-PRA
NDIAL
Hyp
erglycem
ia3
POST-PRA
NDIAL
Hyp
oglycemia
1OVE
RNIGHT
Hyp
erglycem
ia1
OVE
RNIGHT
Hyp
oglycemia
2PR
E-PR
ANDIAL
Hyp
oglycemia
2PR
E-PR
ANDIAL
Hyp
erglycem
ia
Ÿ Decrease dose of oral medication which may affect nocturnal glucose
Ÿ
be too highDose of oral medication may
Ÿ
pump at night or basal insulin dose
Decrease basal rate on insulin
Ÿ
medication which may affect nocturnal glucose
Decrease dose of oral
Ÿ
medication or insulin which may affect nocturnal glucose
Ÿ Decrease basal rate with use of temp basal feature on insulin pump at night
Ÿ Educate patient on effects of exercise on glucose
Decrease dose of oral
Ÿ
insulin may be too highBasal rate or long acting basal
Ÿ
be too highDose of oral medication may
Ÿ
physical activityPrior evening exercise or
Ÿ Prior evening alcohol use Ÿ
alcohol use on glucoseEducate patient on effects of
Ÿ
pump at night or basal insulin dose
Decrease basal rate on insulin
Ÿ
pump at night or basal insulin dose during periods of fasting
Decrease basal rate on insulin
Ÿ
insulin may be too highBasal rate or long acting basal
Ÿ Fasting
Potential Causes ConsiderationsUse “Overlay By Meal” [Night Time Sensor Data]